| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | TRIB2 BCAS3 PCLO APBB1 GBX2 TEAD3 BCOR RUNX3 ARID1A KLF4 TBX18 CCNT2 SALL1 BAZ2A NCOA7 | 6.16e-05 | 753 | 123 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TRIB2 BCAS3 APBB1 GBX2 TEAD3 BCOR ARID1A KLF4 TBX18 SALL1 BAZ2A NCOA7 | 2.55e-04 | 582 | 123 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.61e-04 | 417 | 123 | 10 | GO:0061629 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | DDR1 PIEZO1 DAB2 AMBRA1 RREB1 RUNX3 ARID1A KLF4 CBLB WNK1 JAK3 TBX18 LMO7 TLN1 LIMCH1 CDH1 IL7R | 2.35e-05 | 927 | 119 | 17 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 CUL7 RREB1 KLF4 STK11 PPP2R5D AP2A1 CSPG4 SYNE2 CDH1 | 2.88e-05 | 846 | 119 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 CUL7 RREB1 KLF4 STK11 PPP2R5D AP2A1 CSPG4 SYNE2 CDH1 | 3.66e-05 | 863 | 119 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXM1 BCAS3 DAB2 APBB1 GBX2 SUPT20HL2 ZNF395 TEAD3 RREB1 KLF4 JAK3 CCNT2 KMT2C TSC22D1 PPP2R5D SALL1 MTF1 LMO7 TOX3 NCOA7 NPAS4 | 4.28e-05 | 1390 | 119 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG SCARF2 PIEZO1 AMBRA1 PCDHA5 RUNX3 ARID1A KLF4 CBLB WNK1 JAK3 TBX18 LRFN4 ZFP36L1 TLN1 LPP CDH1 IL7R | 4.49e-05 | 1077 | 119 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TNIK MAG VIL1 DDR1 MYCBP2 DAB2 APBB1 GBX2 CUL7 PAK6 RREB1 RUNX3 FMNL3 ENAM STK11 NBEAL2 PTPRQ CDH1 IL7R | 5.23e-05 | 1194 | 119 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TNIK MAG DDR1 MYCBP2 DAB2 APBB1 CUL7 KLF4 STK11 PPP2R5D AP2A1 CSPG4 CDH1 | 5.34e-05 | 612 | 119 | 13 | GO:0010975 |
| GeneOntologyBiologicalProcess | circulatory system development | FOXM1 STARD13 ANKS6 CAD ACACB BCAS3 DUSP6 GBX2 CUL7 BCOR ARID1A KLF4 WNK1 AXIN2 EPN2 FMNL3 TBX18 STK11 SALL1 ZFP36L1 CSPG4 | 7.26e-05 | 1442 | 119 | 21 | GO:0072359 |
| GeneOntologyBiologicalProcess | cytoplasmic actin-based contraction involved in cell motility | 9.86e-05 | 3 | 119 | 2 | GO:0060327 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | POMT2 TNIK TRIB2 AMER1 MYCBP2 NEK10 DUSP6 DAB2 AMBRA1 CBLB WNK1 AXIN2 CCNT2 STK11 PPP2R5D CSPG4 PTPRQ NCOA7 INAVA LIMCH1 CDC25A | 1.13e-04 | 1488 | 119 | 21 | GO:0031399 |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 1.83e-04 | 49 | 119 | 4 | GO:0071364 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.75e-04 | 22 | 122 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | lamellipodium | 4.09e-04 | 230 | 122 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.78e-04 | 487 | 122 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | apical part of cell | TNIK ABCC1 MGAM DAB2 SHANK2 AP2A1 LMO7 CSPG4 PTPRQ CDH1 USH2A | 7.04e-04 | 592 | 122 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | cell leading edge | 7.07e-04 | 500 | 122 | 10 | GO:0031252 | |
| Domain | AT_hook | 2.87e-06 | 16 | 121 | 4 | PF02178 | |
| Domain | AT_hook | 2.62e-05 | 27 | 121 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.62e-05 | 27 | 121 | 4 | IPR017956 | |
| Domain | DUF4757 | 4.16e-05 | 2 | 121 | 2 | PF15949 | |
| Domain | DUF4757 | 4.16e-05 | 2 | 121 | 2 | IPR031865 | |
| Domain | HMGI/Y_DNA-bd_CS | 4.61e-05 | 31 | 121 | 4 | IPR000637 | |
| Domain | ARM-type_fold | 3.66e-04 | 339 | 121 | 9 | IPR016024 | |
| Domain | WHEP_TRS_1 | 4.11e-04 | 5 | 121 | 2 | PS00762 | |
| Domain | WHEP-TRS | 4.11e-04 | 5 | 121 | 2 | SM00991 | |
| Domain | WHEP-TRS | 4.11e-04 | 5 | 121 | 2 | PF00458 | |
| Domain | WHEP-TRS_dom | 4.11e-04 | 5 | 121 | 2 | IPR000738 | |
| Domain | WHEP_TRS_2 | 4.11e-04 | 5 | 121 | 2 | PS51185 | |
| Domain | CPSASE_1 | 4.11e-04 | 5 | 121 | 2 | PS00866 | |
| Domain | CPSASE_2 | 6.14e-04 | 6 | 121 | 2 | PS00867 | |
| Domain | - | 6.14e-04 | 6 | 121 | 2 | 1.10.287.10 | |
| Domain | APC_su10/DOC_dom | 8.56e-04 | 7 | 121 | 2 | IPR004939 | |
| Domain | DOC | 8.56e-04 | 7 | 121 | 2 | PS51284 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 8.56e-04 | 7 | 121 | 2 | IPR005479 | |
| Domain | BC-like_N | 8.56e-04 | 7 | 121 | 2 | IPR005481 | |
| Domain | ANAPC10 | 8.56e-04 | 7 | 121 | 2 | PF03256 | |
| Domain | CPSase_L_D2 | 8.56e-04 | 7 | 121 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 8.56e-04 | 7 | 121 | 2 | PF00289 | |
| Domain | APC10 | 8.56e-04 | 7 | 121 | 2 | SM01337 | |
| Domain | S15_NS1_RNA-bd | 1.14e-03 | 8 | 121 | 2 | IPR009068 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 LZTR1 MYCBP2 BCAS3 PIEZO1 AMBRA1 GBX2 ZNF395 ARID1A KLF4 WNK1 PLEKHG5 MADD JAK3 PRR12 KMT2C SHANK2 AP2A1 TMEM259 NBEAL2 TLN1 CSPG4 ANKRD34A NUP188 MBD5 | 1.41e-13 | 1105 | 124 | 25 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 PAK6 WNK1 MADD EPN2 ZFP36L1 LMO7 SYNE2 LPP NCOA7 LIMCH1 DOP1B KIF1C | 1.80e-09 | 861 | 124 | 18 | 36931259 |
| Pubmed | FOXM1 LZTR1 AHCTF1 GBX2 RUNX3 ARID1A KLF4 ZDHHC20 TSC22D1 SALL1 ZFP36L1 MTF1 BAZ2A LPP TOX3 ACIN1 DOP1B | 4.82e-09 | 808 | 124 | 17 | 20412781 | |
| Pubmed | ABCC1 GARS1 DAB2 CUL7 ARID1A STK11 HEATR6 AP2A1 TLN1 LPP ACIN1 NUP188 CDH1 JPT2 | 6.70e-08 | 634 | 124 | 14 | 34591612 | |
| Pubmed | EPRS1 CAD MYCBP2 AHCTF1 APBB1 BCOR ARID1A KMT2C BAZ2A LMO7 TLN1 LPP ACIN1 | 9.13e-08 | 549 | 124 | 13 | 38280479 | |
| Pubmed | AMER1 ACACB STXBP4 CUL7 TEAD3 ARID1A WNK1 PPP2R5D AP2A1 LMO7 KIF1C | 6.29e-07 | 446 | 124 | 11 | 24255178 | |
| Pubmed | STARD13 VIL1 EPRS1 AMER1 ACACB PCLO GARS1 TEX14 ARID1A KLF4 STK11 SHANK2 AP2A1 LMO7 CSPG4 SYNE2 ACIN1 LIMCH1 CDH1 | 8.79e-07 | 1442 | 124 | 19 | 35575683 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK MAG ABCC1 ANKS6 LZTR1 SCARF2 APBB1 PAK6 EPN2 ZDHHC20 NBEAL2 CSPG4 | 9.90e-07 | 569 | 124 | 12 | 30639242 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK EPRS1 ACACB STXBP4 AHCTF1 APBB1 BCOR WNK1 BAZ2A TLN1 LPP ACIN1 NCOA7 PRR14L JPT2 | 1.28e-06 | 934 | 124 | 15 | 33916271 |
| Pubmed | 1.57e-06 | 225 | 124 | 8 | 12168954 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.50e-06 | 430 | 124 | 10 | 35044719 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXM1 AHCTF1 GBX2 ZNF395 TEAD3 RREB1 RUNX3 KLF4 TBX18 TSC22D1 SALL1 ZFP36L1 MTF1 TOX3 | 4.72e-06 | 908 | 124 | 14 | 19274049 |
| Pubmed | 5.21e-06 | 10 | 124 | 3 | 20145138 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | COBLL1 PAK6 EPN2 SHANK2 LMO7 TLN1 LPP INAVA LIMCH1 CDH1 JPT2 | 6.11e-06 | 565 | 124 | 11 | 25468996 |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28848051 | ||
| Pubmed | CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities. | 1.26e-05 | 2 | 124 | 2 | 30890477 | |
| Pubmed | AXIN2 and CDH1 polymorphisms, tooth agenesis, and oral clefts. | 1.26e-05 | 2 | 124 | 2 | 18683894 | |
| Pubmed | Mouse germ cell clusters form by aggregation as well as clonal divisions. | 1.26e-05 | 2 | 124 | 2 | 22245112 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34424445 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24292671 | ||
| Pubmed | Novel interactions between FOXM1 and CDC25A regulate the cell cycle. | 1.26e-05 | 2 | 124 | 2 | 23240008 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22155367 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32617970 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21289093 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20356845 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30924295 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7481769 | ||
| Pubmed | 1.37e-05 | 503 | 124 | 10 | 16964243 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 ABCC1 AHCTF1 ZNF395 TEAD3 RREB1 BCOR ARID1A KLF4 PRR12 KMT2C AP2A1 BAZ2A LMO7 ACIN1 NUP188 | 1.53e-05 | 1294 | 124 | 16 | 30804502 |
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 28028137 | ||
| Pubmed | Pbx1-dependent control of VMC differentiation kinetics underlies gross renal vascular patterning. | 1.95e-05 | 15 | 124 | 3 | 26138478 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | STARD13 ANKS6 AMER1 MYCBP2 COBLL1 GARS1 AMBRA1 RREB1 WNK1 EPN2 PPP2R5D AP2A1 LMO7 PTPRQ ANKRD34A KIF1C | 1.97e-05 | 1321 | 124 | 16 | 27173435 |
| Pubmed | ABCC1 CAD LZTR1 MYCBP2 STXBP4 DUSP6 CUL7 BCOR ARID1A MADD PPP2R5D SYNE2 LPP CDC25A | 2.37e-05 | 1049 | 124 | 14 | 27880917 | |
| Pubmed | Activated Hedgehog-GLI Signaling Causes Congenital Ureteropelvic Junction Obstruction. | 2.39e-05 | 16 | 124 | 3 | 29109083 | |
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 18045842 | ||
| Pubmed | EPRS1 AMER1 STXBP4 AHCTF1 BCOR KLF4 WNK1 MADD STK11 KMT2C LPP ACIN1 NUP188 CDH1 | 3.39e-05 | 1084 | 124 | 14 | 11544199 | |
| Pubmed | 3.45e-05 | 251 | 124 | 7 | 29778605 | ||
| Pubmed | 3.65e-05 | 347 | 124 | 8 | 17114649 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25967717 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20190194 | ||
| Pubmed | Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. | 3.77e-05 | 3 | 124 | 2 | 23376074 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 30429017 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 21177849 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 17537734 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15996891 | ||
| Pubmed | Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration. | 3.77e-05 | 3 | 124 | 2 | 10366628 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 36420658 | ||
| Pubmed | Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer. | 3.77e-05 | 3 | 124 | 2 | 25879941 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 31790342 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 29436678 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25509356 | ||
| Pubmed | A profound deficiency in thymic progenitor cells in mice lacking Jak3. | 3.77e-05 | 3 | 124 | 2 | 11034372 | |
| Pubmed | Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. | 3.77e-05 | 3 | 124 | 2 | 24297939 | |
| Pubmed | EPRS1 CAD AMER1 GARS1 TEAD3 ARID1A AXIN2 CCNT2 AP2A1 LMO7 TLN1 ACIN1 INAVA LIMCH1 CDH1 | 3.95e-05 | 1247 | 124 | 15 | 27684187 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.96e-05 | 351 | 124 | 8 | 38297188 | |
| Pubmed | ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. | 4.11e-05 | 19 | 124 | 3 | 26116176 | |
| Pubmed | Impaired stria vascularis integrity upon loss of E-cadherin in basal cells. | 4.82e-05 | 20 | 124 | 3 | 21925491 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.14e-05 | 588 | 124 | 10 | 38580884 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 5.61e-05 | 477 | 124 | 9 | 31300519 | |
| Pubmed | 6.48e-05 | 486 | 124 | 9 | 20936779 | ||
| Pubmed | 7.44e-05 | 23 | 124 | 3 | 20159597 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 34645806 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 23088431 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 26334097 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 31093876 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 20432435 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 24385580 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 10336464 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 24251807 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 17339320 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 30553475 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.51e-05 | 398 | 124 | 8 | 35016035 | |
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 9.61e-05 | 25 | 124 | 3 | 34391772 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 EPRS1 MYCBP2 DAB2 RREB1 BCOR CCNT2 BAZ2A LMO7 ACIN1 LIMCH1 | 1.07e-04 | 774 | 124 | 11 | 15302935 |
| Pubmed | 1.11e-04 | 407 | 124 | 8 | 12693553 | ||
| Pubmed | 1.22e-04 | 653 | 124 | 10 | 22586326 | ||
| Pubmed | 1.23e-04 | 529 | 124 | 9 | 14621295 | ||
| Pubmed | Stat5a/b are essential for normal lymphoid development and differentiation. | 1.25e-04 | 5 | 124 | 2 | 16418296 | |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 9858510 | ||
| Pubmed | Direct interaction between Kit and the interleukin-7 receptor. | 1.25e-04 | 5 | 124 | 2 | 17554063 | |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 21555575 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 24045232 | ||
| Pubmed | 1.36e-04 | 28 | 124 | 3 | 20346939 | ||
| Pubmed | 1.83e-04 | 230 | 124 | 6 | 35449600 | ||
| Pubmed | 1.86e-04 | 329 | 124 | 7 | 17474147 | ||
| Pubmed | Numb expression and asymmetric versus symmetric cell division in distal embryonic lung epithelium. | 1.87e-04 | 6 | 124 | 2 | 22713487 | |
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 23109710 | ||
| Pubmed | 1.87e-04 | 6 | 124 | 2 | 25866077 | ||
| Pubmed | Intronic delay is essential for oscillatory expression in the segmentation clock. | 1.87e-04 | 6 | 124 | 2 | 21300886 | |
| Pubmed | Pancreatic pericytes originate from the embryonic pancreatic mesenchyme. | 1.87e-04 | 6 | 124 | 2 | 30771302 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.91e-04 | 232 | 124 | 6 | 25515538 | |
| Pubmed | TNIK EPRS1 CAD ACACB MYCBP2 TSPOAP1 BCAS3 PCLO APBB1 MADD PPP2R5D SHANK2 JPH3 | 2.22e-04 | 1139 | 124 | 13 | 36417873 | |
| Pubmed | Cdx2 regulates endo-lysosomal function and epithelial cell polarity. | 2.23e-04 | 33 | 124 | 3 | 20551175 | |
| Pubmed | Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. | 2.23e-04 | 33 | 124 | 3 | 16618389 | |
| Pubmed | 2.23e-04 | 33 | 124 | 3 | 24727668 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.35e-04 | 154 | 124 | 5 | 16055720 | |
| Pubmed | Disruption of Hox9,10,11 function results in cellular level lineage infidelity in the kidney. | 2.62e-04 | 7 | 124 | 2 | 29679048 | |
| Pubmed | 2.62e-04 | 7 | 124 | 2 | 19801644 | ||
| Pubmed | 2.62e-04 | 7 | 124 | 2 | 29451339 | ||
| Pubmed | 2.62e-04 | 7 | 124 | 2 | 27918915 | ||
| Interaction | TOP3B interactions | EPRS1 ANKS6 CAD LZTR1 MYCBP2 BCAS3 PIEZO1 AMBRA1 GBX2 ZNF395 ARID1A KLF4 WNK1 PLEKHG5 MADD AXIN2 JAK3 PRR12 KMT2C SHANK2 AP2A1 TMEM259 CIAO1 NBEAL2 TLN1 CSPG4 ANKRD34A ACIN1 NUP188 MBD5 ADAMTSL4 | 4.40e-10 | 1470 | 121 | 31 | int:TOP3B |
| Interaction | YWHAH interactions | AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 ZNF395 PAK6 WNK1 PLEKHG5 MADD EPN2 IFIH1 ZFP36L1 LMO7 SYNE2 LPP NCOA7 LIMCH1 CDC25A DOP1B KIF1C | 5.98e-07 | 1102 | 121 | 22 | int:YWHAH |
| Interaction | YWHAG interactions | CAD AMER1 MYCBP2 BCAS3 STXBP4 COBLL1 APBB1 ZNF395 CUL7 PAK6 WNK1 PLEKHG5 EPN2 STK11 LRFN4 ZFP36L1 LMO7 SYNE2 ANKRD34A ACIN1 CDC25A IL7R KIF1C | 1.27e-06 | 1248 | 121 | 23 | int:YWHAG |
| Interaction | SOX7 interactions | 9.98e-06 | 82 | 121 | 6 | int:SOX7 | |
| Interaction | YWHAZ interactions | CAD MYCBP2 COBLL1 ZNF395 CUL7 PAK6 BCOR ARID1A WNK1 PLEKHG5 MADD EPN2 ZFP36L1 LMO7 NBEAL2 SYNE2 ANKRD34A PRR14L CDC25A CDH1 KIF1C | 3.60e-05 | 1319 | 121 | 21 | int:YWHAZ |
| GeneFamily | Fibronectin type III domain containing | 7.18e-04 | 160 | 80 | 5 | 555 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.04e-03 | 11 | 80 | 2 | 1025 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 1.76e-05 | 171 | 124 | 7 | M39234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.20e-05 | 177 | 124 | 7 | M39245 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | STARD13 PIEZO1 COBLL1 RUNX3 AXIN2 FMNL3 TBX18 ZFP36L1 GUCY1A1 COL21A1 TLN1 CSPG4 LPP NCOA7 | 2.48e-05 | 795 | 124 | 14 | M39050 |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 4.51e-05 | 198 | 124 | 7 | M8624 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 4.65e-05 | 199 | 124 | 7 | M8031 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP | 4.65e-05 | 199 | 124 | 7 | M8748 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 5.78e-05 | 141 | 124 | 6 | M39235 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 6.15e-05 | 208 | 124 | 7 | M39233 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-09 | 191 | 123 | 9 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-09 | 194 | 123 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-09 | 194 | 123 | 9 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.48e-08 | 199 | 123 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 190 | 123 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-06 | 195 | 123 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-06 | 196 | 123 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.33e-06 | 198 | 123 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-06 | 198 | 123 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.33e-06 | 198 | 123 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 123 | 7 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 123 | 7 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 123 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 123 | 7 | c11365653c69a5dfb37946231f8af05149a61a71 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.42e-06 | 200 | 123 | 7 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 123 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.42e-06 | 200 | 123 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-06 | 200 | 123 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-06 | 200 | 123 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-06 | 161 | 123 | 6 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-06 | 163 | 123 | 6 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.85e-06 | 170 | 123 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.12e-06 | 171 | 123 | 6 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.57e-06 | 176 | 123 | 6 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-06 | 177 | 123 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 178 | 123 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 179 | 123 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 179 | 123 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 181 | 123 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-05 | 182 | 123 | 6 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 183 | 123 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 183 | 123 | 6 | d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 183 | 123 | 6 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 184 | 123 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 184 | 123 | 6 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-05 | 185 | 123 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.27e-05 | 185 | 123 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.27e-05 | 185 | 123 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.27e-05 | 185 | 123 | 6 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 185 | 123 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 186 | 123 | 6 | e2ba9f3518d87a44537a57a648df17ab98fbbb39 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 186 | 123 | 6 | fda3415222f688ef5cd8de4b0b79daa2493c585f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-05 | 186 | 123 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-05 | 186 | 123 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.31e-05 | 186 | 123 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.31e-05 | 186 | 123 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.35e-05 | 187 | 123 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 187 | 123 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-05 | 187 | 123 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.35e-05 | 187 | 123 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 187 | 123 | 6 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 187 | 123 | 6 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.35e-05 | 187 | 123 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 188 | 123 | 6 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 189 | 123 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 189 | 123 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.48e-05 | 190 | 123 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.48e-05 | 190 | 123 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-05 | 190 | 123 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 190 | 123 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 190 | 123 | 6 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 1.52e-05 | 191 | 123 | 6 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 191 | 123 | 6 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.57e-05 | 192 | 123 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-05 | 192 | 123 | 6 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.57e-05 | 192 | 123 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-05 | 192 | 123 | 6 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.57e-05 | 192 | 123 | 6 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.57e-05 | 192 | 123 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.62e-05 | 193 | 123 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 193 | 123 | 6 | 46d5d1f8150ebbc7f1941b96ab184491e5c1210b | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-05 | 193 | 123 | 6 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 194 | 123 | 6 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 194 | 123 | 6 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-05 | 194 | 123 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | HSPCs-Mk_prog.|World / Lineage and Cell class | 1.66e-05 | 194 | 123 | 6 | 5049f4f102844d766eca577e809cf21f7908a9d2 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 123 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | d77423d0ec64b397c6d1eec181c5fc0acaa92d63 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 123 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 1.71e-05 | 195 | 123 | 6 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 123 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 123 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.71e-05 | 195 | 123 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 123 | 6 | f5bf4797972185afa76638293166abd536e5472f | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 197 | 123 | 6 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | LAM-Epithelial|LAM / Condition, Lineage and Cell class | 1.81e-05 | 197 | 123 | 6 | e5cf07061f6d9db7f12ac17209b267373fa2270b | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.81e-05 | 197 | 123 | 6 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.81e-05 | 197 | 123 | 6 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 198 | 123 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 198 | 123 | 6 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-gd_T|ICU-SEP / Disease, condition lineage and cell class | 1.87e-05 | 198 | 123 | 6 | b40899f8f5f32420fb4574069dd7afd9e7e70d91 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.87e-05 | 198 | 123 | 6 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | 21-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.92e-05 | 199 | 123 | 6 | 8eb8b086c38960200578a9fe8853ca6e894ddee4 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.92e-05 | 199 | 123 | 6 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | distal-3-Epithelial-Club|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.92e-05 | 199 | 123 | 6 | 1a0c3506df2438f5be40a8ea72effe5f8ebd35c4 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-05 | 199 | 123 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.92e-05 | 199 | 123 | 6 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.92e-05 | 199 | 123 | 6 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.92e-05 | 199 | 123 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 9.77e-07 | 194 | 121 | 9 | 4284_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.06e-06 | 196 | 121 | 9 | 3083_UP | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A | 1.06e-06 | 196 | 121 | 9 | 2491_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HG-U133A | 1.11e-06 | 197 | 121 | 9 | 1925_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.16e-06 | 198 | 121 | 9 | 5635_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; HL60; HG-U133A | 1.21e-06 | 199 | 121 | 9 | 1747_UP | |
| Drug | Cantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A | 5.96e-06 | 182 | 121 | 8 | 3075_UP | |
| Drug | WY-14643; Down 200; 100uM; PC3; HG-U133A | 8.82e-06 | 192 | 121 | 8 | 464_DN | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 9.51e-06 | 194 | 121 | 8 | 1211_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.51e-06 | 194 | 121 | 8 | 7423_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 2328_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 121 | 8 | 4412_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.14e-05 | 199 | 121 | 8 | 2302_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A | 1.14e-05 | 199 | 121 | 8 | 1739_UP | |
| Drug | pyrachlostrobin | STARD13 DDR1 PIEZO1 COBLL1 DAB2 TEAD3 RREB1 KLF4 WNK1 TLN1 CSPG4 LPP ANKRD34A ADAMTSL4 KIF1C | 2.67e-05 | 811 | 121 | 15 | ctd:C513428 |
| Drug | AC1O1I4V | 2.80e-05 | 2 | 121 | 2 | CID000516923 | |
| Drug | ZrO2 | 3.50e-05 | 35 | 121 | 4 | CID000062395 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.41e-05 | 176 | 121 | 7 | 1212_DN | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 5.08e-05 | 180 | 121 | 7 | 7094_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 5.45e-05 | 182 | 121 | 7 | 6896_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 5.84e-05 | 184 | 121 | 7 | 4430_DN | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 6.47e-05 | 187 | 121 | 7 | 7402_DN | |
| Drug | Alsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A | 7.39e-05 | 191 | 121 | 7 | 7078_UP | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 7.63e-05 | 192 | 121 | 7 | 7556_UP | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.89e-05 | 193 | 121 | 7 | 6646_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 6893_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 3747_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 6347_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 2223_UP | |
| Drug | Dicyclopentadienyl magnesium | 8.37e-05 | 3 | 121 | 2 | CID011984632 | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 8.41e-05 | 195 | 121 | 7 | 505_DN | |
| Drug | Prenylamine lactate [69-43-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 5070_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 2906_UP | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 8.41e-05 | 195 | 121 | 7 | 1903_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 6614_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 6648_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 3969_UP | |
| Drug | 6-mercaptopurine monohydrate; Up 200; 10uM; PC3; HG-U133A | 8.69e-05 | 196 | 121 | 7 | 667_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 4549_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 3256_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 5232_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | 8.97e-05 | 197 | 121 | 7 | 1909_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 7148_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 4226_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 2305_UP | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 4199_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 6611_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 4598_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 6663_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 5867_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 5118_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 2088_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HG-U133A | 9.26e-05 | 198 | 121 | 7 | 665_UP | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 6320_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 4126_UP | |
| Drug | rapamycin; Up 200; 0.1uM; HL60; HG-U133A | 9.55e-05 | 199 | 121 | 7 | 362_UP | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; HL60; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 2476_UP | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 4170_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 3760_UP | |
| Drug | methyllithium | 1.33e-04 | 19 | 121 | 3 | CID000142321 | |
| Drug | Cai2 | 1.67e-04 | 4 | 121 | 2 | CID000066244 | |
| Disease | Colorectal Carcinoma | ABCC1 CAD PAK6 ARID1A WNK1 AXIN2 STK11 KMT2C LMO7 NPAP1 ACIN1 CDH1 JPH3 | 5.95e-06 | 702 | 120 | 13 | C0009402 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.31e-05 | 139 | 120 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | lymphocyte count | TNIK ABCC1 TRIB2 BCAS3 PIEZO1 COBLL1 ZNF395 RREB1 RUNX3 IFIH1 STK11 ZNF469 CILP2 ZFP36L1 GUCY1A1 TLN1 LPP IL7R | 2.63e-05 | 1464 | 120 | 18 | EFO_0004587 |
| Disease | hepatoblastoma (is_marker_for) | 2.88e-05 | 15 | 120 | 3 | DOID:687 (is_marker_for) | |
| Disease | conotruncal heart malformations, parental genotype effect measurement | 4.91e-05 | 3 | 120 | 2 | EFO_0005939, MONDO_0016581 | |
| Disease | 17alpha-hydroxypregnanolone glucuronide measurement | 4.91e-05 | 3 | 120 | 2 | EFO_0800363 | |
| Disease | hemoglobin A1 measurement | 5.45e-05 | 520 | 120 | 10 | EFO_0007629 | |
| Disease | Adenoid Cystic Carcinoma | 5.66e-05 | 100 | 120 | 5 | C0010606 | |
| Disease | Stomach Carcinoma | 8.27e-05 | 21 | 120 | 3 | C0699791 | |
| Disease | Carcinoma, Granular Cell | 1.14e-04 | 116 | 120 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.14e-04 | 116 | 120 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.14e-04 | 116 | 120 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.14e-04 | 116 | 120 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.14e-04 | 116 | 120 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.14e-04 | 116 | 120 | 5 | C0001418 | |
| Disease | cutaneous melanoma, hair color | 1.21e-04 | 62 | 120 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | psoriasis | 1.31e-04 | 273 | 120 | 7 | EFO_0000676 | |
| Disease | hormone measurement, progesterone measurement | 1.63e-04 | 5 | 120 | 2 | EFO_0004730, EFO_0007004 | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.63e-04 | 5 | 120 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | diabetes mellitus | 1.73e-04 | 68 | 120 | 4 | EFO_0000400 | |
| Disease | hair colour measurement | 2.14e-04 | 615 | 120 | 10 | EFO_0007822 | |
| Disease | stomach cancer (is_implicated_in) | 2.16e-04 | 72 | 120 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Bilateral Wilms Tumor | 2.22e-04 | 29 | 120 | 3 | C2930471 | |
| Disease | juvenile idiopathic arthritis | 2.40e-04 | 74 | 120 | 4 | EFO_0002609 | |
| Disease | red blood cell density measurement | STARD13 VIL1 TRIB2 BCAS3 STXBP4 PIEZO1 COBLL1 RREB1 WNK1 SALL1 ZFP36L1 POLI | 2.54e-04 | 880 | 120 | 12 | EFO_0007978 |
| Disease | Thyroid preparation use measurement | 2.69e-04 | 217 | 120 | 6 | EFO_0009933 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 3.40e-04 | 7 | 120 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | Hodgkins lymphoma | 3.56e-04 | 82 | 120 | 4 | EFO_0000183 | |
| Disease | Nephroblastoma | 4.25e-04 | 36 | 120 | 3 | C0027708 | |
| Disease | HbA1c measurement | 4.46e-04 | 675 | 120 | 10 | EFO_0004541 | |
| Disease | Embryonal Rhabdomyosarcoma | 4.52e-04 | 8 | 120 | 2 | C0206656 | |
| Disease | pregnanediol-3-glucuronide measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0800341 | |
| Disease | X-12844 measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0021339 | |
| Disease | testosterone measurement | FOXM1 STARD13 VIL1 DDR1 SLC22A25 AMER1 COBLL1 RREB1 ARID1A SLC22A24 ZFP36L1 SYNE2 USH2A JPT2 | 6.89e-04 | 1275 | 120 | 14 | EFO_0004908 |
| Disease | estrogen measurement | 7.23e-04 | 10 | 120 | 2 | EFO_0011007 | |
| Disease | Leukemia, Myelocytic, Acute | 7.24e-04 | 173 | 120 | 5 | C0023467 | |
| Disease | multiple sclerosis | 7.39e-04 | 594 | 120 | 9 | MONDO_0005301 | |
| Disease | creatinine measurement | VIL1 BCAS3 DAB2 RREB1 ARID1A KLF4 CBLB CILP2 CSPG4 LPP NCOA7 MBD5 | 7.57e-04 | 995 | 120 | 12 | EFO_0004518 |
| Disease | basophil count | 8.26e-04 | 483 | 120 | 8 | EFO_0005090 | |
| Disease | free androgen index | 8.68e-04 | 374 | 120 | 7 | EFO_0007005 | |
| Disease | hematocrit | STARD13 TRIB2 BCAS3 PIEZO1 COBLL1 RREB1 PGAP6 PRR12 SALL1 ZFP36L1 TOX3 NCOA7 | 8.69e-04 | 1011 | 120 | 12 | EFO_0004348 |
| Disease | Congenital Abnormality | 8.81e-04 | 11 | 120 | 2 | C0000768 | |
| Disease | IGF-1 measurement | 8.83e-04 | 488 | 120 | 8 | EFO_0004627 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 1.05e-03 | 12 | 120 | 2 | EFO_0800573 | |
| Disease | stomach carcinoma (is_implicated_in) | 1.05e-03 | 12 | 120 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 1.05e-03 | 49 | 120 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | hypothyroidism | 1.10e-03 | 284 | 120 | 6 | EFO_0004705 | |
| Disease | reticulocyte count | EPRS1 BCAS3 PIEZO1 COBLL1 RREB1 RUNX3 ZNF469 ZFP36L1 SYNE2 NCOA7 CDH1 KIF1C | 1.15e-03 | 1045 | 120 | 12 | EFO_0007986 |
| Disease | lymphocyte measurement | 1.35e-03 | 117 | 120 | 4 | EFO_0803546 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.45e-03 | 14 | 120 | 2 | DOID:627 (is_implicated_in) | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 1.45e-03 | 14 | 120 | 2 | DOID:3969 (is_marker_for) | |
| Disease | memory performance | 1.45e-03 | 409 | 120 | 7 | EFO_0004874 | |
| Disease | Malignant neoplasm of breast | FOXM1 ABCC1 SCARF2 STXBP4 CFHR5 ARID1A WNK1 MAMDC4 SYNE2 TOX3 ANKRD34A CDH1 | 1.45e-03 | 1074 | 120 | 12 | C0006142 |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.48e-03 | 301 | 120 | 6 | DOID:684 (is_marker_for) | |
| Disease | pulse pressure measurement | NEK10 COBLL1 PCDHA5 RREB1 MADD FMNL3 TBX18 CILP2 GUCY1A1 MTF1 COL21A1 LPP CDC25A MBD5 | 1.59e-03 | 1392 | 120 | 14 | EFO_0005763 |
| Disease | autoimmune thyroid disease | 1.78e-03 | 126 | 120 | 4 | EFO_0006812 | |
| Disease | celiac disease | 1.78e-03 | 126 | 120 | 4 | EFO_0001060 | |
| Disease | mean corpuscular hemoglobin concentration | MAG VIL1 ABCC1 STXBP4 PIEZO1 COBLL1 GARS1 GPR152 RREB1 PGAP6 ZFP36L1 CDH1 | 1.85e-03 | 1105 | 120 | 12 | EFO_0004528 |
| Disease | triglycerides to total lipids in large HDL percentage | 1.90e-03 | 60 | 120 | 3 | EFO_0022330 | |
| Disease | Benign neoplasm of stomach | 2.14e-03 | 17 | 120 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.14e-03 | 17 | 120 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.14e-03 | 17 | 120 | 2 | C0154060 | |
| Disease | triacylglycerol 56:9 measurement | 2.14e-03 | 17 | 120 | 2 | EFO_0010436 | |
| Disease | sphingomyelin 14:0 measurement | 2.14e-03 | 17 | 120 | 2 | EFO_0010390 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.18e-03 | 63 | 120 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | bilirubin measurement | 2.25e-03 | 442 | 120 | 7 | EFO_0004570 | |
| Disease | insomnia measurement | 2.28e-03 | 443 | 120 | 7 | EFO_0007876 | |
| Disease | autoimmune thyroid disease, Hashimoto's thyroiditis, Graves disease | 2.40e-03 | 18 | 120 | 2 | EFO_0003779, EFO_0004237, EFO_0006812 | |
| Disease | Omenn Syndrome | 2.68e-03 | 19 | 120 | 2 | C2700553 | |
| Disease | stomach cancer (is_marker_for) | 2.74e-03 | 142 | 120 | 4 | DOID:10534 (is_marker_for) | |
| Disease | chronic kidney disease | 2.79e-03 | 235 | 120 | 5 | EFO_0003884 | |
| Disease | Severe Combined Immunodeficiency | 2.97e-03 | 20 | 120 | 2 | C0085110 | |
| Disease | androsterone glucuronide measurement | 2.97e-03 | 20 | 120 | 2 | EFO_0800317 | |
| Disease | monocyte percentage of leukocytes | 3.05e-03 | 731 | 120 | 9 | EFO_0007989 | |
| Disease | type 1 diabetes mellitus | 3.16e-03 | 242 | 120 | 5 | MONDO_0005147 | |
| Disease | obsolete_red blood cell distribution width | MAG ABCC1 BCAS3 PIEZO1 GARS1 WNK1 PLEKHG5 PRSS36 CILP2 ZFP36L1 TMEM259 SYNE2 CDH1 | 3.34e-03 | 1347 | 120 | 13 | EFO_0005192 |
| Disease | psoriasis, type 2 diabetes mellitus | 3.58e-03 | 75 | 120 | 3 | EFO_0000676, MONDO_0005148 | |
| Disease | serum non-albumin protein measurement | 3.65e-03 | 361 | 120 | 6 | EFO_0004568 | |
| Disease | Mammary Neoplasms, Experimental | 3.75e-03 | 155 | 120 | 4 | C0024668 | |
| Disease | CCL11 measurement | 3.92e-03 | 23 | 120 | 2 | EFO_0005188 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEGVASLLPPDFQSS | 176 | Q9UKV3 | |
| PGTPAILSSPEFQAS | 321 | Q6UXC1 | |
| FSLPQTPQTDNPSEG | 521 | Q9Y2D5 | |
| TSAFPAPVPLNSGNI | 306 | O60583 | |
| AEPFSANGSPQTELP | 201 | Q6UY14 | |
| FSSSDPNIRAPQLPG | 426 | A8MYA2 | |
| ADEPPSLDPVQSFSQ | 1296 | Q6UVK1 | |
| DTQSPFQTGTPLERP | 96 | Q96LS8 | |
| SSDFPPSLTQPAPDQ | 401 | Q9UIF9 | |
| PPTNFSSLELEPRGQ | 391 | Q08345 | |
| AQPSLGPTPEEAFLS | 691 | O95782 | |
| RTLPPSSNPTGAEFD | 181 | Q14738 | |
| QTGATPFSNPSLAPE | 731 | Q9Y2T1 | |
| DSDSSFTQNLPELPP | 791 | Q5JTC6 | |
| EGTLTFPAQSLSPEP | 336 | O00213 | |
| FESVPSSGSQLPPLE | 606 | Q9C0C7 | |
| QSHGPSDTPQPLLDF | 766 | Q9H6U6 | |
| NGLPPSSIFLSPNEA | 631 | Q6W2J9 | |
| NSQIPTPTDGPSFTV | 1051 | Q53SF7 | |
| PSPGFCTSPSEIQLQ | 176 | Q69YU3 | |
| AATLQFTTLPAGPPD | 966 | O95153 | |
| SPQDRPSFSALGPQL | 1081 | P52333 | |
| LIPSQEPFPASDNSG | 41 | O00763 | |
| DPFSTLGPNAVLSPQ | 2101 | O14497 | |
| SDIFAPPVSEPSGQA | 456 | P98082 | |
| AQSLPSDQPVGTFSP | 306 | Q9NQU5 | |
| PTAPFNLADINDVSP | 181 | O43474 | |
| APLLNFSPGNLSVDP | 346 | P18428 | |
| FSQPGTISRPTSQDP | 2116 | Q8NEZ4 | |
| PSNDLQSTPSTEFNP | 461 | Q8WXG6 | |
| QPTQPASELPSGRLF | 376 | Q8N653 | |
| SSPESTQSPFEGFPQ | 146 | O60732 | |
| SSPESTQSPFEGFPQ | 181 | O60732 | |
| EGFPQSPLQIPVSSS | 296 | O60732 | |
| EGFPQSPLQIPVSSS | 436 | O60732 | |
| EGFPQSPLQIPVSSS | 471 | O60732 | |
| GEDSLSSLHFPQSPP | 701 | O60732 | |
| SNPEPSVAFELPSRN | 436 | P20916 | |
| QSTFETPSPSPGFQI | 396 | Q86VH4 | |
| NNGTTSPDPFESQPL | 481 | O95208 | |
| TQRQLPADSPGTPFL | 2256 | Q9Y3R5 | |
| IPSVPSSTPEGQLYD | 1966 | O43451 | |
| NLFGSPEEATPSSRP | 26 | Q9H910 | |
| GVAPNLPTIPSASDF | 2381 | Q2LD37 | |
| SDPFVDLASGQVPLP | 856 | Q13191 | |
| AQLPFTTPGPFTTND | 86 | A6NNH2 | |
| NPPPEEISTGTQSTF | 3726 | Q9Y6V0 | |
| SQGSPEPIEPNFFTA | 1086 | Q6ZWH5 | |
| SPGSIFQPQLADVSP | 326 | Q14999 | |
| FIPDTPELGSPQSVS | 446 | Q6AI08 | |
| GFQNPETLADIPASP | 81 | Q13670 | |
| PTTHNGELEPSFSPN | 416 | O43896 | |
| DDSSALPSISGNFPP | 76 | Q93052 | |
| LPSPTSPFSSLSQDQ | 986 | Q8WWI1 | |
| RPGSFTPTEPQTQLD | 321 | Q8TDT2 | |
| TNSTLPPPFSLQSGI | 411 | P16871 | |
| NPLGTSFPDDTAVQP | 111 | Q9HCN3 | |
| FSPSLPQGPTSTDNP | 771 | Q9Y5H7 | |
| FNGISREPEPPSNET | 26 | Q6ZSS7 | |
| PDSPPQDFSVKQLSG | 896 | Q9UMZ3 | |
| PIPGAFQDSALSPTQ | 16 | Q5K4E3 | |
| TFPDPLTSPLQGQLT | 476 | Q8IUM7 | |
| AFSIDSLIGSPPQPS | 21 | P52951 | |
| EDLQPPSALSAPFTN | 176 | Q8IVF7 | |
| VGTPANSLEFSDPCP | 266 | Q8ND61 | |
| NPELTDLPSPSFENA | 96 | Q9BYX4 | |
| SELTSNVFPEGLPPS | 266 | Q96P44 | |
| PRGLSSNQPLPFSDE | 476 | Q68DC2 | |
| PPPSINNGDTTSFPL | 451 | Q9BXR6 | |
| PPSSTEALNDSQEFP | 181 | Q4ZIN3 | |
| TDPLGSPDVFTRSNP | 241 | Q9P267 | |
| PLDLISVPFGNSSPS | 681 | Q08050 | |
| PFDGDSITPTENPNT | 1081 | Q9NRM1 | |
| SEPNNEPLFSPASEV | 2111 | Q8WYP5 | |
| GSPLSNSQPSFPVEI | 196 | Q16828 | |
| SPVILSGPPQSFSEE | 316 | Q9UNA4 | |
| LNGTFPNTSEPDTEP | 101 | Q6T423 | |
| ASANSVFPSPLPNIG | 396 | Q9NSC2 | |
| AVPSEFANGLSPTPV | 951 | Q9NSC2 | |
| LPSQLFEPSSNLGPN | 1056 | Q9NSC2 | |
| GSSSPDISFLQPLSP | 471 | Q3KP66 | |
| DADLPPNTSPFTAEL | 616 | P12830 | |
| STEPNLSSFLNDPNP | 471 | Q9UPQ0 | |
| SSEPGNFIPLFTPQS | 191 | P30304 | |
| NTSGSQTRLEPPFPA | 1936 | Q5THK1 | |
| SDPPTLNGITFSIPE | 656 | P33527 | |
| TPIQGTSELNPFSDP | 231 | Q13761 | |
| SLTQTLEAPPQDFPA | 3956 | O75445 | |
| PGLSTFPSPNQITLD | 521 | Q9Y3M8 | |
| EYIPGQPPLSQSSDS | 871 | P07814 | |
| SAQGSSSQLPKPFDP | 241 | Q8NB59 | |
| SLFTEGTLDPQAPDP | 576 | Q8IWB6 | |
| NTNSDPLDPSFPVEF | 391 | Q9UKY4 | |
| QNPASPLPSFDEVDS | 6771 | Q8WXH0 | |
| VFPSSPPSGLSDEPQ | 301 | Q5JRV8 | |
| LNGTFPNTNEPDTEP | 101 | Q8N4F4 | |
| PGQVLFVPDANSPSS | 151 | Q8NI08 | |
| PTLQFQDVTGPSFLP | 86 | Q6ZSG1 | |
| PDGPSLQLPAQTFSS | 666 | Q14872 | |
| PSLPPTNGSPTFFED | 1686 | Q6ZNJ1 | |
| PITGNDLSPPVSFNL | 266 | P41250 | |
| LLDQNSQTPPPSPFS | 2676 | O75592 | |
| SPAFQPPEIANGLDT | 216 | Q15831 | |
| NATSSEDFPPPSLLQ | 51 | Q15714 | |
| LSSGPDLTLQFQAPP | 606 | Q6UXD5 | |
| TPLAANSPGPTLDFT | 196 | P59797 | |
| SSLSLQDPPFSPPAN | 166 | Q9ULL5 | |
| GPQASTLSLFSSPPE | 131 | Q6ZWJ1 | |
| DSSFILGNPATPAPV | 911 | Q9NZP6 | |
| ALSDVFSLPSQPPSG | 1736 | Q9UPX8 | |
| SSPAPLQFFLNTPEG | 631 | P0C7V6 | |
| EDPNSDPQQPTFSLT | 281 | O76071 | |
| TLVNLEPAPGFSANP | 761 | Q8IUL8 | |
| PVFSLCIPNGDTSPD | 406 | Q8N7C3 | |
| TLSPTSLQDFVAPGP | 821 | O94827 | |
| NSNLSSGPLPIFPLE | 756 | P09327 | |
| PTLPDGTNNPFAFSS | 241 | Q07352 | |
| SPPSPQDSLSDQEGY | 291 | Q07352 | |
| DPNLPPRSESFSISG | 561 | Q9UKE5 | |
| SGSNQPFPIKPLSES | 316 | Q5W0Z9 | |
| PQDPGCTNLLSLSPF | 401 | Q92766 | |
| LTNQAGETFAPPRTP | 441 | O95935 | |
| ASNPEFSSIPAQISP | 1576 | Q9Y490 | |
| SQSFSPNLGSPSPPE | 36 | Q92519 | |
| PPPSSDFLADVVGLQ | 131 | Q96IC2 | |
| SFLEPPSGLEQPSPS | 531 | Q96GP6 | |
| IGQTNPAFSDPPLEA | 251 | Q99594 | |
| PLLEGAAPQPFTTSD | 36 | Q9H8N7 | |
| ENLTSPLFGTLSPPS | 1011 | Q5SRE5 | |
| LPFQALSDPLPSQGS | 86 | O15405 | |
| LSDPLPSQGSEFTPQ | 91 | O15405 | |
| NGTEPSSLPFLDPNA | 141 | P27708 | |
| PGEFLAPVANPSSTA | 1296 | Q96JG9 | |
| CTEPFPNSTNLLPTE | 886 | Q92508 | |
| FPGPSLTQSQQPLED | 1781 | Q9H4A3 | |
| PFSLLAPGQVPNESS | 16 | Q02108 | |
| TPSDLTPDDSPLQSF | 466 | Q8WXH2 | |
| EASPAPLVLSFSGNP | 221 | Q6PJG9 |